Carillion and Laing O’Rourke/Interserve were shortlisted by Sandwell & West Birmingham NHS Trust in September 2014 and were due to submit their final bids this month. Balfour Beatty withdrew at an earlier stage and now Laing O’Rourke/Interserve has followed suit.
HealthInvestor website reports that the health trust is satisfied that continuing the procurement process with just the one remaining bidder presents no legal or commercial problems. Confirmation of contract award is expected later in the year.
The Midland Metropolitan Hospital, also known as the Mid Met, is new acute hospital that is set to open in 2018/19. It is being developed under the terms of the government’s PF2 regime, with £100m of public money and £253m from private finance.
It will be built on a 17-acre brownfield industrial site on Grove Lane in Smethwick. It is expected to be seven storeys high and provide 80,600m2 of hospital space, with capacity for approximately 81,455 inpatients and 115,045 outpatients every year.